第一作者机构：[1]Department of Otorhinolaryngology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200336, China
通讯作者：
推荐引用方式(GB/T 7714)：
Li Danping,Li Cong,Shi Song.Letter to the editor: The efficacy and safety of VEGF/VEGFR inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma[J].ORAL ONCOLOGY.2023,145:doi:10.1016/j.oraloncology.2023.106497.
APA：
Li Danping,Li Cong&Shi Song.(2023).Letter to the editor: The efficacy and safety of VEGF/VEGFR inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma.ORAL ONCOLOGY,145,
MLA：
Li Danping,et al."Letter to the editor: The efficacy and safety of VEGF/VEGFR inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma".ORAL ONCOLOGY 145.(2023)
